RankingsPricing
  1. US-listed companies
  2. ARCA biopharma, Inc.

ARCA biopharma, Inc.ABIO

Market cap
$34.58M
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2012		Dec 31,
2013		Dec 31,
2014		Dec 31,
2015		Dec 31,
2016		Dec 31,
2017		Dec 31,
2018		Dec 31,
2019		Dec 31,
2020		Dec 31,
2021		Dec 31,
2022
Research and development424346------5145
General and administrative---------566
Total costs and expenses9599106------101911
Loss from operations-7-4-7-------10-19-11
Interest and other income222------001
Other loss-----------0
Net loss-5-4-7-10-11-16-18-8-5-10-19-10
Basic------------0.69
Diluted------------0.69